Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles

Cimzia(R), The Only PEGylated Anti-TNF, Recommended For Approval In The EU For Rheumatoid Arthritis
UCB announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMEA) has issued a positive opinion recommending that the European Commission grants a marketing authorisation for Cimzia® (certolizumab pegol), in combination with methotrexate (MTX), for the treatment of moderate to severe active rheumatoid arthritis in adult patients when the response to disease-modifying anti-rheumatic drugs (DMARDs) including MTX, has been inadequate. In these patients, Cimzia® can be given as monotherapy in case of intolerance to MTX or when continued treatment with MTX is inappropriate. Cimzia® has been shown to reduce the rate of progression of joint damage as measured by X-ray and to improve physical function, when given in combination with MTX.

Survivors Of Childhood Central Nervous System Cancer Face Persistent Risks As Adults
Long-term survivors of childhood central nervous system (CNS) malignancies remain at risk for death and are at increasing risk for developing subsequent cancers and chronic medical conditions over time, according to a new study published online June 17 in the JNCI.
News of the day
New Study Shows Similar Benefits, No Additional Risks For Seniors Who Have Gastric Bypass
Morbidly obese seniors, age 65 and over, who had laparoscopic gastric bypass surgery lost nearly 76 percent of their excess weight after two years and had low complication rates and short hospital stays comparable to younger surgical patients, according to a new study presented today at the 26th Annual Meeting of the American Society for Metabolic & Bariatric Surgery (ASMBS).
Medical Devices

Lancet Examines Obama Administration's Progress On HIV/AIDS-Related Campaign Pledges

The July issue of the journal Lancet Infectious Diseases examines whether President Obama is fulfilling his campaign promises to tackle HIV/AIDS abroad and domestically. The article states that Obama"s recent appointments of "lauded experts," including Jeffrey Crowley as the new director of the Office of National AIDS Policy, indicate that the U.S. "seems poised to deliver on election promises." Crowley is charged with developing a national strategy for HIV/AIDS aimed at "reducing incidence, increasing the number of people in care, and lowering disparities in care," according to the Lancet. In addition, the Lancet notes other measures the administration has taken to address HIV/AIDS in the U.S., including a joint meeting held in April between the administration, CDC and various federal, civil, and private agencies, at which a new national five-year campaign, "Act Against AIDS," was announced. The Lancet also discussed concerns voiced by advocates and others that available federal funding is not adequate to address the epidemic (Morris, July 2009). This information was reprinted from dailyreports.kff.org with kind permission from the Henry J. Kaiser Family Foundation. You can view the entire Kaiser Daily U.S. HIV/AIDS Report, search the archives and sign up for email delivery at dailyreports.kff.org. © Henry J. Kaiser Family Foundation. All rights reserved.


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009